IBDEI077 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7107,2)
 ;;=^5006641
 ;;^UTILITY(U,$J,358.3,7108,0)
 ;;=E04.0^^42^490^39
 ;;^UTILITY(U,$J,358.3,7108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7108,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,7108,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,7108,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,7109,0)
 ;;=E04.1^^42^490^41
 ;;^UTILITY(U,$J,358.3,7109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7109,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,7109,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,7109,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,7110,0)
 ;;=E04.2^^42^490^40
 ;;^UTILITY(U,$J,358.3,7110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7110,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,7110,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,7110,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,7111,0)
 ;;=E01.1^^42^490^36
 ;;^UTILITY(U,$J,358.3,7111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7111,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,7111,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,7111,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,7112,0)
 ;;=E05.00^^42^490^56
 ;;^UTILITY(U,$J,358.3,7112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7112,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,7112,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,7112,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,7113,0)
 ;;=E05.01^^42^490^55
 ;;^UTILITY(U,$J,358.3,7113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7113,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,7113,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,7113,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,7114,0)
 ;;=E05.90^^42^490^58
 ;;^UTILITY(U,$J,358.3,7114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7114,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,7114,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,7114,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,7115,0)
 ;;=E05.91^^42^490^57
 ;;^UTILITY(U,$J,358.3,7115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7115,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,7115,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,7115,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,7116,0)
 ;;=E89.0^^42^490^50
 ;;^UTILITY(U,$J,358.3,7116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7116,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,7116,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,7116,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,7117,0)
 ;;=E03.2^^42^490^32
 ;;^UTILITY(U,$J,358.3,7117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7117,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,7117,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,7117,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,7118,0)
 ;;=E03.9^^42^490^33
 ;;^UTILITY(U,$J,358.3,7118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7118,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,7118,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,7118,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,7119,0)
 ;;=E06.0^^42^490^53
 ;;^UTILITY(U,$J,358.3,7119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7119,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,7119,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,7119,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,7120,0)
 ;;=E06.1^^42^490^54
 ;;^UTILITY(U,$J,358.3,7120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7120,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,7120,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,7120,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,7121,0)
 ;;=C73.^^42^490^37
 ;;^UTILITY(U,$J,358.3,7121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7121,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,7121,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,7121,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,7122,0)
 ;;=E10.21^^42^490^8
 ;;^UTILITY(U,$J,358.3,7122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7122,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,7122,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,7122,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,7123,0)
 ;;=E10.9^^42^490^12
 ;;^UTILITY(U,$J,358.3,7123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7123,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,7123,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,7123,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,7124,0)
 ;;=E11.21^^42^490^17
 ;;^UTILITY(U,$J,358.3,7124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7124,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,7124,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,7124,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,7125,0)
 ;;=E11.39^^42^490^18
 ;;^UTILITY(U,$J,358.3,7125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7125,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,7125,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,7125,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,7126,0)
 ;;=E11.43^^42^490^15
 ;;^UTILITY(U,$J,358.3,7126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7126,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,7126,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,7126,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,7127,0)
 ;;=E11.59^^42^490^13
 ;;^UTILITY(U,$J,358.3,7127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7127,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,7127,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,7127,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,7128,0)
 ;;=E11.618^^42^490^14
 ;;^UTILITY(U,$J,358.3,7128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7128,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,7128,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,7128,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,7129,0)
 ;;=E11.621^^42^490^16
 ;;^UTILITY(U,$J,358.3,7129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7129,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,7129,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,7129,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,7130,0)
 ;;=E11.622^^42^490^20
 ;;^UTILITY(U,$J,358.3,7130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7130,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,7130,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,7130,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,7131,0)
 ;;=E11.65^^42^490^19
 ;;^UTILITY(U,$J,358.3,7131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7131,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,7131,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,7131,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,7132,0)
 ;;=E11.9^^42^490^21
 ;;^UTILITY(U,$J,358.3,7132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7132,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,7132,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,7132,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,7133,0)
 ;;=E13.9^^42^490^22
 ;;^UTILITY(U,$J,358.3,7133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7133,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,7133,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,7133,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,7134,0)
 ;;=E16.2^^42^490^29
 ;;^UTILITY(U,$J,358.3,7134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7134,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,7134,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,7134,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,7135,0)
 ;;=E20.0^^42^490^34
 ;;^UTILITY(U,$J,358.3,7135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7135,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,7135,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,7135,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,7136,0)
 ;;=E20.9^^42^490^30
 ;;^UTILITY(U,$J,358.3,7136,1,0)
 ;;=^358.31IA^4^2
